ارتقای ایمنی و پیشگیری از مصدومیت ها

1. Haider A, Saha L, Basu D. Patterns of utilization of antipsychotic drugs and direct medical costs among patients with schizophrenia in a tertiary care hospital. World Journal of Psychiatry. 2026;16(1):109365. https://doi.org/10.5498/wjp.v16.i1.109365

2. Goruntla N, Ssesanga J, Bommireddy BR, Thammisetty DP, Kasturi Vishwanathasetty V, Ezeonwumelu JO, Bukke SP. Evaluation of rational drug use based on who/inrud core drug use indicators in a secondary care hospital: a cross-sectional study in western Uganda. Drug, Healthcare and Patient Safety. 2023:125-135. https://doi.org/10.2147/DHPS.S424050

3. Minaei H, Peikanpour M, Yousefi N, Peymani P, Peiravian F, Shobeiri N, Majd ZK, Shamsaee J. Country pharmaceutical situation on access, quality, and rational use of medicines: An evidence from a middle-income country. Iranian Journal of Pharmaceutical Research: IJPR. 2019;18(4):2191. https://doi.org/10.22037/ijpr.2019.111636.13273

4. Azami-Aghdash S, Mohseni M, Etemadi M, Royani S, Moosavi A, Nakhaee M. Prevalence and cause of self-medication in Iran: a systematic review and meta-analysis article. Iranian Journal of Public Health. 2015;44(12):1580. https://pmc.ncbi.nlm.nih.gov/articles/PMC4724731/

5. Ofori-Asenso R, Agyeman AA. Irrational use of medicines—a summary of key concepts. Pharmacy. 2016;4(4):35. https://doi.org/10.3390/pharmacy4040035

6. Khoshnoud MJ, Hajian A, Asemani O. Drug counseling for herbal medicines: patients’ perspectives on the professional performance of pharmacists in urban pharmacies. BMC Complementary Medicine and Therapies. 2025;25(1):335. https://doi.org/10.1186/s12906-025-05079-3

7. Jahani MA, Pasha MR, Hashemi SN, Soltani SA, Nikbakht HA, Mahmoudi G. The model for induced drug demand management in Iranian hospitals: a qualitative study. BMC Research Notes. 2025;18(1):443. https://doi.org/10.1186/s13104-025-07194-3

8. Sami R, Salehi K, Sadegh R, Solgi H, Atashi V. Barriers to rational antibiotic prescription in Iran: A descriptive qualitative study. Antimicrobial Resistance & Infection Control. 2022;11(1):109. https://doi.org/10.1186/s13756-022-01151-6

9. Raeis Zadeh MM, Borhani M, Soleymani F, Yazdizadeh B, Nikfar S. Impact of Delisting Non-Prescription Medicines from Health Insurance Coverage on Physicians’ Prescribing Behaviour in Iran: A Qualitative Study. Journal of Research in Pharmacy Practice. 2026;15(1):1. https://doi.org/10.4103/jrpp.jrpp_53_25